nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—ABCB1—melanoma	0.191	1	CbGaD
Fluphenazine—CYP2E1—Dacarbazine—melanoma	0.0854	0.219	CbGbCtD
Fluphenazine—CYP1A2—Carmustine—melanoma	0.0815	0.209	CbGbCtD
Fluphenazine—CYP1A2—Vemurafenib—melanoma	0.0644	0.165	CbGbCtD
Fluphenazine—CYP2D6—Vemurafenib—melanoma	0.0531	0.136	CbGbCtD
Fluphenazine—CYP1A2—Dacarbazine—melanoma	0.0494	0.126	CbGbCtD
Fluphenazine—ABCB1—Dactinomycin—melanoma	0.0375	0.0959	CbGbCtD
Fluphenazine—ABCB1—Docetaxel—melanoma	0.0193	0.0495	CbGbCtD
Fluphenazine—Edema cerebral—Carmustine—melanoma	0.00792	0.0832	CcSEcCtD
Fluphenazine—Edema cerebral—Temozolomide—melanoma	0.00765	0.0804	CcSEcCtD
Fluphenazine—Brain oedema—Carmustine—melanoma	0.00429	0.045	CcSEcCtD
Fluphenazine—Brain oedema—Temozolomide—melanoma	0.00414	0.0435	CcSEcCtD
Fluphenazine—Pigmentation disorder—Temozolomide—melanoma	0.00355	0.0372	CcSEcCtD
Fluphenazine—CALM2—ear—melanoma	0.00347	0.0688	CbGeAlD
Fluphenazine—CALM1—ear—melanoma	0.00345	0.0685	CbGeAlD
Fluphenazine—HTR2A—hindlimb—melanoma	0.00218	0.0432	CbGeAlD
Fluphenazine—Photosensitivity—Vemurafenib—melanoma	0.00192	0.0201	CcSEcCtD
Fluphenazine—HTR2A—appendage—melanoma	0.00187	0.037	CbGeAlD
Fluphenazine—CALM2—endothelium—melanoma	0.00186	0.0369	CbGeAlD
Fluphenazine—CALM1—endothelium—melanoma	0.00185	0.0367	CbGeAlD
Fluphenazine—CALM2—hair follicle—melanoma	0.00183	0.0363	CbGeAlD
Fluphenazine—CALM2—blood vessel—melanoma	0.00171	0.034	CbGeAlD
Fluphenazine—CALM1—blood vessel—melanoma	0.00171	0.0339	CbGeAlD
Fluphenazine—Tenderness—Bleomycin—melanoma	0.00161	0.0169	CcSEcCtD
Fluphenazine—Extrapyramidal disorder—Temozolomide—melanoma	0.00157	0.0165	CcSEcCtD
Fluphenazine—Eosinophilia—Vemurafenib—melanoma	0.00144	0.0151	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Docetaxel—melanoma	0.00142	0.0149	CcSEcCtD
Fluphenazine—Menstruation irregular—Docetaxel—melanoma	0.00142	0.0149	CcSEcCtD
Fluphenazine—Liver injury—Temozolomide—melanoma	0.00141	0.0148	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Vemurafenib—melanoma	0.00133	0.0139	CcSEcCtD
Fluphenazine—Leukocytosis—Carmustine—melanoma	0.0013	0.0137	CcSEcCtD
Fluphenazine—CALM2—neck—melanoma	0.00123	0.0243	CbGeAlD
Fluphenazine—CALM1—neck—melanoma	0.00122	0.0242	CbGeAlD
Fluphenazine—CALM3—eye—melanoma	0.00116	0.023	CbGeAlD
Fluphenazine—CALM3—retina—melanoma	0.00115	0.0228	CbGeAlD
Fluphenazine—Oedema peripheral—Vemurafenib—melanoma	0.00115	0.012	CcSEcCtD
Fluphenazine—HTR2A—endothelium—melanoma	0.00113	0.0224	CbGeAlD
Fluphenazine—DRD3—head—melanoma	0.00113	0.0223	CbGeAlD
Fluphenazine—Gynaecomastia—Carmustine—melanoma	0.0011	0.0115	CcSEcCtD
Fluphenazine—HTR6—head—melanoma	0.00108	0.0215	CbGeAlD
Fluphenazine—Dermatitis atopic—Docetaxel—melanoma	0.00106	0.0112	CcSEcCtD
Fluphenazine—HTR2A—blood vessel—melanoma	0.00104	0.0206	CbGeAlD
Fluphenazine—Erythema—Vemurafenib—melanoma	0.00101	0.0106	CcSEcCtD
Fluphenazine—Lethargy—Dactinomycin—melanoma	0.00097	0.0102	CcSEcCtD
Fluphenazine—Nasal congestion—Temozolomide—melanoma	0.000944	0.00991	CcSEcCtD
Fluphenazine—CALM3—mammalian vulva—melanoma	0.000922	0.0183	CbGeAlD
Fluphenazine—CALM2—eye—melanoma	0.000913	0.0181	CbGeAlD
Fluphenazine—Dermatitis exfoliative—Temozolomide—melanoma	0.000911	0.00956	CcSEcCtD
Fluphenazine—CALM1—eye—melanoma	0.000908	0.018	CbGeAlD
Fluphenazine—CALM2—retina—melanoma	0.000904	0.0179	CbGeAlD
Fluphenazine—CALM1—retina—melanoma	0.0009	0.0179	CbGeAlD
Fluphenazine—DRD2—eye—melanoma	0.000839	0.0166	CbGeAlD
Fluphenazine—Pancytopenia—Bleomycin—melanoma	0.000836	0.00878	CcSEcCtD
Fluphenazine—DRD2—retina—melanoma	0.000831	0.0165	CbGeAlD
Fluphenazine—Anaphylactic shock—Vemurafenib—melanoma	0.000827	0.00868	CcSEcCtD
Fluphenazine—Dysphagia—Dactinomycin—melanoma	0.000821	0.00862	CcSEcCtD
Fluphenazine—DRD1—head—melanoma	0.000806	0.016	CbGeAlD
Fluphenazine—Skin disorder—Vemurafenib—melanoma	0.000803	0.00843	CcSEcCtD
Fluphenazine—CALM2—skin of body—melanoma	0.000794	0.0157	CbGeAlD
Fluphenazine—CALM1—skin of body—melanoma	0.00079	0.0157	CbGeAlD
Fluphenazine—Pneumonia—Bleomycin—melanoma	0.00079	0.00829	CcSEcCtD
Fluphenazine—Hepatocellular injury—Docetaxel—melanoma	0.000787	0.00827	CcSEcCtD
Fluphenazine—Pancytopenia—Dactinomycin—melanoma	0.00078	0.00819	CcSEcCtD
Fluphenazine—Hypotension—Vemurafenib—melanoma	0.000772	0.00811	CcSEcCtD
Fluphenazine—Dysphagia—Carmustine—melanoma	0.000769	0.00807	CcSEcCtD
Fluphenazine—HTR2A—neck—melanoma	0.000744	0.0148	CbGeAlD
Fluphenazine—Dysphagia—Temozolomide—melanoma	0.000743	0.0078	CcSEcCtD
Fluphenazine—Pneumonia—Dactinomycin—melanoma	0.000737	0.00773	CcSEcCtD
Fluphenazine—Pancytopenia—Carmustine—melanoma	0.00073	0.00766	CcSEcCtD
Fluphenazine—CALM2—mammalian vulva—melanoma	0.000724	0.0144	CbGeAlD
Fluphenazine—CALM1—mammalian vulva—melanoma	0.000721	0.0143	CbGeAlD
Fluphenazine—Decreased appetite—Vemurafenib—melanoma	0.000719	0.00754	CcSEcCtD
Fluphenazine—Constipation—Vemurafenib—melanoma	0.000707	0.00742	CcSEcCtD
Fluphenazine—Pancytopenia—Temozolomide—melanoma	0.000705	0.00741	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Temozolomide—melanoma	0.00069	0.00725	CcSEcCtD
Fluphenazine—Pneumonia—Carmustine—melanoma	0.000689	0.00724	CcSEcCtD
Fluphenazine—Agranulocytosis—Dactinomycin—melanoma	0.000683	0.00717	CcSEcCtD
Fluphenazine—ABCB1—blood vessel—melanoma	0.000681	0.0135	CbGeAlD
Fluphenazine—Photosensitivity reaction—Temozolomide—melanoma	0.000678	0.00712	CcSEcCtD
Fluphenazine—Pneumonia—Temozolomide—melanoma	0.000666	0.00699	CcSEcCtD
Fluphenazine—HRH1—eye—melanoma	0.000663	0.0131	CbGeAlD
Fluphenazine—Body temperature increased—Vemurafenib—melanoma	0.000653	0.00686	CcSEcCtD
Fluphenazine—HTR2C—head—melanoma	0.000626	0.0124	CbGeAlD
Fluphenazine—Erythema—Bleomycin—melanoma	0.000614	0.00644	CcSEcCtD
Fluphenazine—Hypersensitivity—Vemurafenib—melanoma	0.000609	0.00639	CcSEcCtD
Fluphenazine—Oedema peripheral—Carmustine—melanoma	0.000606	0.00636	CcSEcCtD
Fluphenazine—Oedema peripheral—Temozolomide—melanoma	0.000586	0.00615	CcSEcCtD
Fluphenazine—Pruritus—Vemurafenib—melanoma	0.000585	0.00614	CcSEcCtD
Fluphenazine—Lethargy—Docetaxel—melanoma	0.000583	0.00612	CcSEcCtD
Fluphenazine—Erythema—Dactinomycin—melanoma	0.000572	0.00601	CcSEcCtD
Fluphenazine—HTR2A—eye—melanoma	0.000553	0.011	CbGeAlD
Fluphenazine—Leukopenia—Bleomycin—melanoma	0.000549	0.00577	CcSEcCtD
Fluphenazine—HTR2A—retina—melanoma	0.000548	0.0109	CbGeAlD
Fluphenazine—Erythema—Carmustine—melanoma	0.000536	0.00562	CcSEcCtD
Fluphenazine—HTR1A—head—melanoma	0.000527	0.0105	CbGeAlD
Fluphenazine—HRH1—mammalian vulva—melanoma	0.000526	0.0104	CbGeAlD
Fluphenazine—CALM2—head—melanoma	0.000518	0.0103	CbGeAlD
Fluphenazine—Headache—Vemurafenib—melanoma	0.000518	0.00544	CcSEcCtD
Fluphenazine—Erythema—Temozolomide—melanoma	0.000518	0.00543	CcSEcCtD
Fluphenazine—ADRA2A—mammalian vulva—melanoma	0.000516	0.0102	CbGeAlD
Fluphenazine—CALM1—head—melanoma	0.000516	0.0102	CbGeAlD
Fluphenazine—Leukopenia—Dactinomycin—melanoma	0.000512	0.00538	CcSEcCtD
Fluphenazine—Vision blurred—Carmustine—melanoma	0.000505	0.0053	CcSEcCtD
Fluphenazine—Anaphylactic shock—Bleomycin—melanoma	0.000501	0.00526	CcSEcCtD
Fluphenazine—Dysphagia—Docetaxel—melanoma	0.000494	0.00519	CcSEcCtD
Fluphenazine—Agitation—Carmustine—melanoma	0.000492	0.00517	CcSEcCtD
Fluphenazine—Nausea—Vemurafenib—melanoma	0.000491	0.00515	CcSEcCtD
Fluphenazine—Vision blurred—Temozolomide—melanoma	0.000488	0.00512	CcSEcCtD
Fluphenazine—Leukopenia—Carmustine—melanoma	0.000479	0.00503	CcSEcCtD
Fluphenazine—DRD2—head—melanoma	0.000476	0.00945	CbGeAlD
Fluphenazine—Agitation—Temozolomide—melanoma	0.000476	0.00499	CcSEcCtD
Fluphenazine—Angioedema—Temozolomide—melanoma	0.000473	0.00497	CcSEcCtD
Fluphenazine—Pancytopenia—Docetaxel—melanoma	0.000469	0.00493	CcSEcCtD
Fluphenazine—Hypotension—Bleomycin—melanoma	0.000468	0.00491	CcSEcCtD
Fluphenazine—Leukopenia—Temozolomide—melanoma	0.000463	0.00486	CcSEcCtD
Fluphenazine—Hypertension—Carmustine—melanoma	0.000462	0.00485	CcSEcCtD
Fluphenazine—CALM3—lymph node—melanoma	0.000462	0.00916	CbGeAlD
Fluphenazine—Hypertension—Temozolomide—melanoma	0.000447	0.00469	CcSEcCtD
Fluphenazine—Dyspnoea—Bleomycin—melanoma	0.000446	0.00469	CcSEcCtD
Fluphenazine—Pneumonia—Docetaxel—melanoma	0.000443	0.00465	CcSEcCtD
Fluphenazine—Decreased appetite—Bleomycin—melanoma	0.000435	0.00457	CcSEcCtD
Fluphenazine—Dry mouth—Temozolomide—melanoma	0.000431	0.00452	CcSEcCtD
Fluphenazine—Tachycardia—Carmustine—melanoma	0.000427	0.00448	CcSEcCtD
Fluphenazine—Anaphylactic shock—Temozolomide—melanoma	0.000422	0.00443	CcSEcCtD
Fluphenazine—Agranulocytosis—Docetaxel—melanoma	0.000411	0.00432	CcSEcCtD
Fluphenazine—Skin disorder—Temozolomide—melanoma	0.00041	0.00431	CcSEcCtD
Fluphenazine—Hypotension—Carmustine—melanoma	0.000408	0.00429	CcSEcCtD
Fluphenazine—Decreased appetite—Dactinomycin—melanoma	0.000406	0.00426	CcSEcCtD
Fluphenazine—Urticaria—Bleomycin—melanoma	0.000398	0.00418	CcSEcCtD
Fluphenazine—Body temperature increased—Bleomycin—melanoma	0.000396	0.00416	CcSEcCtD
Fluphenazine—Dyspnoea—Carmustine—melanoma	0.00039	0.00409	CcSEcCtD
Fluphenazine—Oedema peripheral—Docetaxel—melanoma	0.00039	0.00409	CcSEcCtD
Fluphenazine—Somnolence—Carmustine—melanoma	0.000389	0.00408	CcSEcCtD
Fluphenazine—Decreased appetite—Carmustine—melanoma	0.00038	0.00399	CcSEcCtD
Fluphenazine—Dyspnoea—Temozolomide—melanoma	0.000377	0.00395	CcSEcCtD
Fluphenazine—HRH1—head—melanoma	0.000376	0.00746	CbGeAlD
Fluphenazine—Somnolence—Temozolomide—melanoma	0.000376	0.00394	CcSEcCtD
Fluphenazine—Constipation—Carmustine—melanoma	0.000374	0.00392	CcSEcCtD
Fluphenazine—ADRA2A—head—melanoma	0.000369	0.00733	CbGeAlD
Fluphenazine—Body temperature increased—Dactinomycin—melanoma	0.000369	0.00388	CcSEcCtD
Fluphenazine—Hypersensitivity—Bleomycin—melanoma	0.000369	0.00387	CcSEcCtD
Fluphenazine—Decreased appetite—Temozolomide—melanoma	0.000367	0.00386	CcSEcCtD
Fluphenazine—CALM2—lymph node—melanoma	0.000363	0.00719	CbGeAlD
Fluphenazine—CYP2E1—head—melanoma	0.000361	0.00717	CbGeAlD
Fluphenazine—Constipation—Temozolomide—melanoma	0.000361	0.00379	CcSEcCtD
Fluphenazine—CALM1—lymph node—melanoma	0.000361	0.00716	CbGeAlD
Fluphenazine—ABCB1—retina—melanoma	0.000359	0.00713	CbGeAlD
Fluphenazine—Pruritus—Bleomycin—melanoma	0.000354	0.00372	CcSEcCtD
Fluphenazine—Body temperature increased—Carmustine—melanoma	0.000346	0.00363	CcSEcCtD
Fluphenazine—Erythema—Docetaxel—melanoma	0.000344	0.00361	CcSEcCtD
Fluphenazine—Hypersensitivity—Dactinomycin—melanoma	0.000344	0.00361	CcSEcCtD
Fluphenazine—Urticaria—Temozolomide—melanoma	0.000336	0.00352	CcSEcCtD
Fluphenazine—Body temperature increased—Temozolomide—melanoma	0.000334	0.00351	CcSEcCtD
Fluphenazine—Muscle spasms—Docetaxel—melanoma	0.000331	0.00347	CcSEcCtD
Fluphenazine—Hypersensitivity—Carmustine—melanoma	0.000322	0.00338	CcSEcCtD
Fluphenazine—HTR2A—head—melanoma	0.000314	0.00623	CbGeAlD
Fluphenazine—Hypersensitivity—Temozolomide—melanoma	0.000311	0.00327	CcSEcCtD
Fluphenazine—Leukopenia—Docetaxel—melanoma	0.000308	0.00323	CcSEcCtD
Fluphenazine—Pruritus—Temozolomide—melanoma	0.000299	0.00314	CcSEcCtD
Fluphenazine—Nausea—Bleomycin—melanoma	0.000297	0.00312	CcSEcCtD
Fluphenazine—Hypertension—Docetaxel—melanoma	0.000297	0.00312	CcSEcCtD
Fluphenazine—ABCB1—mammalian vulva—melanoma	0.000288	0.00571	CbGeAlD
Fluphenazine—Dry mouth—Docetaxel—melanoma	0.000287	0.00301	CcSEcCtD
Fluphenazine—CYP2D6—head—melanoma	0.000286	0.00568	CbGeAlD
Fluphenazine—Anaphylactic shock—Docetaxel—melanoma	0.000281	0.00295	CcSEcCtD
Fluphenazine—Nausea—Dactinomycin—melanoma	0.000277	0.00291	CcSEcCtD
Fluphenazine—Tachycardia—Docetaxel—melanoma	0.000274	0.00288	CcSEcCtD
Fluphenazine—Headache—Carmustine—melanoma	0.000274	0.00287	CcSEcCtD
Fluphenazine—Skin disorder—Docetaxel—melanoma	0.000273	0.00286	CcSEcCtD
Fluphenazine—Headache—Temozolomide—melanoma	0.000265	0.00278	CcSEcCtD
Fluphenazine—HRH1—lymph node—melanoma	0.000263	0.00522	CbGeAlD
Fluphenazine—Hypotension—Docetaxel—melanoma	0.000263	0.00276	CcSEcCtD
Fluphenazine—Nausea—Carmustine—melanoma	0.00026	0.00273	CcSEcCtD
Fluphenazine—ADRA2A—lymph node—melanoma	0.000259	0.00513	CbGeAlD
Fluphenazine—Nausea—Temozolomide—melanoma	0.000251	0.00263	CcSEcCtD
Fluphenazine—Dyspnoea—Docetaxel—melanoma	0.00025	0.00263	CcSEcCtD
Fluphenazine—Somnolence—Docetaxel—melanoma	0.00025	0.00262	CcSEcCtD
Fluphenazine—Decreased appetite—Docetaxel—melanoma	0.000244	0.00256	CcSEcCtD
Fluphenazine—Constipation—Docetaxel—melanoma	0.00024	0.00252	CcSEcCtD
Fluphenazine—Body temperature increased—Docetaxel—melanoma	0.000222	0.00233	CcSEcCtD
Fluphenazine—Hypersensitivity—Docetaxel—melanoma	0.000207	0.00217	CcSEcCtD
Fluphenazine—ABCB1—head—melanoma	0.000206	0.00408	CbGeAlD
Fluphenazine—Pruritus—Docetaxel—melanoma	0.000199	0.00209	CcSEcCtD
Fluphenazine—Headache—Docetaxel—melanoma	0.000176	0.00185	CcSEcCtD
Fluphenazine—Nausea—Docetaxel—melanoma	0.000167	0.00175	CcSEcCtD
Fluphenazine—Flupentixol—ABCB1—melanoma	0.000152	0.17	CrCbGaD
Fluphenazine—ABCB1—lymph node—melanoma	0.000144	0.00286	CbGeAlD
Fluphenazine—Nefazodone—ABCB1—melanoma	8.49e-05	0.0951	CrCbGaD
Fluphenazine—Triflupromazine—ABCB1—melanoma	8.27e-05	0.0927	CrCbGaD
Fluphenazine—Acepromazine—ALB—melanoma	8.02e-05	0.0898	CrCbGaD
Fluphenazine—Trazodone—ABCB1—melanoma	7.86e-05	0.088	CrCbGaD
Fluphenazine—Thioproperazine—ALB—melanoma	7.84e-05	0.0878	CrCbGaD
Fluphenazine—Pipotiazine—ALB—melanoma	7.71e-05	0.0864	CrCbGaD
Fluphenazine—Thiothixene—ALB—melanoma	7.71e-05	0.0864	CrCbGaD
Fluphenazine—Trifluoperazine—ABCB1—melanoma	5.09e-05	0.057	CrCbGaD
Fluphenazine—Quetiapine—ABCB1—melanoma	4.93e-05	0.0552	CrCbGaD
Fluphenazine—Chlorpromazine—ALB—melanoma	4.18e-05	0.0468	CrCbGaD
Fluphenazine—Chlorpromazine—ABCB1—melanoma	3.99e-05	0.0447	CrCbGaD
Fluphenazine—CALM3—Signaling Pathways—ERBB2—melanoma	3.58e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—melanoma	3.56e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2—melanoma	3.56e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MAPK1—melanoma	3.55e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EGFR—melanoma	3.55e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—melanoma	3.54e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—melanoma	3.54e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CB—melanoma	3.54e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTEN—melanoma	3.53e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTEN—melanoma	3.53e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—melanoma	3.53e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—melanoma	3.53e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—melanoma	3.52e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MDM2—melanoma	3.52e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MDM2—melanoma	3.52e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—melanoma	3.51e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—melanoma	3.51e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—melanoma	3.51e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—melanoma	3.51e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.5e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—melanoma	3.5e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—melanoma	3.47e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB2—melanoma	3.47e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB2—melanoma	3.47e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CD—melanoma	3.46e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MAPK1—melanoma	3.46e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—melanoma	3.46e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—melanoma	3.45e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MAPK1—melanoma	3.45e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—melanoma	3.45e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	3.44e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MAPK1—melanoma	3.43e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MAPK1—melanoma	3.43e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—melanoma	3.43e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—melanoma	3.43e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CB—melanoma	3.42e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CB—melanoma	3.42e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—melanoma	3.42e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—melanoma	3.4e-06	1.25e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—melanoma	3.38e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—melanoma	3.38e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—melanoma	3.38e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—melanoma	3.37e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	3.36e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—melanoma	3.35e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—melanoma	3.35e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—melanoma	3.35e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CG—melanoma	3.34e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—melanoma	3.34e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—melanoma	3.34e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—melanoma	3.33e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NFKB1—melanoma	3.33e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—melanoma	3.32e-06	1.22e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1B—melanoma	3.32e-06	1.22e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—melanoma	3.32e-06	1.22e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—melanoma	3.32e-06	1.22e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—melanoma	3.29e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—melanoma	3.29e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—melanoma	3.29e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—melanoma	3.28e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—melanoma	3.28e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—melanoma	3.28e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—melanoma	3.27e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—melanoma	3.27e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—melanoma	3.27e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—melanoma	3.27e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—melanoma	3.25e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—melanoma	3.25e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—melanoma	3.25e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—melanoma	3.24e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—melanoma	3.24e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—melanoma	3.23e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—melanoma	3.23e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—melanoma	3.22e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—melanoma	3.22e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARG—melanoma	3.22e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1B—melanoma	3.21e-06	1.18e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1B—melanoma	3.21e-06	1.18e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CB—melanoma	3.2e-06	1.18e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK3—melanoma	3.2e-06	1.18e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—melanoma	3.19e-06	1.17e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—melanoma	3.18e-06	1.17e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—melanoma	3.17e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—melanoma	3.15e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—melanoma	3.15e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK3—melanoma	3.14e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—melanoma	3.14e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—melanoma	3.14e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK3—melanoma	3.14e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—melanoma	3.13e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—melanoma	3.13e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—melanoma	3.13e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—melanoma	3.11e-06	1.14e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—melanoma	3.1e-06	1.14e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—melanoma	3.08e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—melanoma	3.08e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—melanoma	3.07e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1A—melanoma	3.06e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—melanoma	3.06e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—melanoma	3.06e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—melanoma	3.06e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—melanoma	3.06e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—melanoma	3.05e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—melanoma	3.05e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK1—melanoma	3.04e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NFKB1—melanoma	3.04e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—melanoma	3.04e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—melanoma	3.03e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—melanoma	3.03e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—melanoma	3.02e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CB—melanoma	3.02e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—melanoma	3.01e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—melanoma	2.99e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK1—melanoma	2.99e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—melanoma	2.99e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—melanoma	2.99e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—melanoma	2.99e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—melanoma	2.99e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK1—melanoma	2.99e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—melanoma	2.99e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—melanoma	2.98e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—melanoma	2.98e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—melanoma	2.98e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—melanoma	2.98e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—melanoma	2.98e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—melanoma	2.97e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—melanoma	2.97e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1A—melanoma	2.96e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1A—melanoma	2.96e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—melanoma	2.96e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—melanoma	2.96e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—melanoma	2.95e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NFKB1—melanoma	2.94e-06	1.08e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NFKB1—melanoma	2.94e-06	1.08e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CD—melanoma	2.94e-06	1.08e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—melanoma	2.91e-06	1.07e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—melanoma	2.9e-06	1.07e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—melanoma	2.89e-06	1.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—melanoma	2.88e-06	1.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—melanoma	2.88e-06	1.06e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—melanoma	2.87e-06	1.06e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK3—melanoma	2.86e-06	1.05e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—melanoma	2.86e-06	1.05e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—melanoma	2.86e-06	1.05e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—melanoma	2.86e-06	1.05e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—melanoma	2.85e-06	1.05e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—melanoma	2.83e-06	1.04e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—melanoma	2.83e-06	1.04e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—melanoma	2.82e-06	1.04e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—melanoma	2.82e-06	1.04e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—melanoma	2.78e-06	1.02e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—melanoma	2.78e-06	1.02e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—melanoma	2.77e-06	1.02e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—melanoma	2.77e-06	1.02e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—melanoma	2.76e-06	1.02e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—melanoma	2.75e-06	1.01e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—melanoma	2.75e-06	1.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—melanoma	2.73e-06	1.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—melanoma	2.73e-06	1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—melanoma	2.73e-06	1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—melanoma	2.72e-06	1e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK1—melanoma	2.72e-06	1e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—melanoma	2.72e-06	1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—melanoma	2.67e-06	9.82e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—melanoma	2.67e-06	9.82e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—melanoma	2.66e-06	9.79e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—melanoma	2.65e-06	9.74e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—melanoma	2.64e-06	9.72e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—melanoma	2.64e-06	9.72e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—melanoma	2.64e-06	9.71e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—melanoma	2.64e-06	9.7e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—melanoma	2.64e-06	9.7e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—melanoma	2.64e-06	9.7e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—melanoma	2.64e-06	9.7e-06	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—melanoma	2.63e-06	9.69e-06	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—melanoma	2.63e-06	9.69e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK3—melanoma	2.61e-06	9.6e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—melanoma	2.61e-06	9.6e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.6e-06	9.55e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—melanoma	2.59e-06	9.54e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—melanoma	2.59e-06	9.53e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—melanoma	2.58e-06	9.48e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—melanoma	2.57e-06	9.46e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CB—melanoma	2.56e-06	9.41e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—melanoma	2.55e-06	9.39e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—melanoma	2.54e-06	9.34e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—melanoma	2.53e-06	9.33e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK3—melanoma	2.53e-06	9.29e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK3—melanoma	2.53e-06	9.29e-06	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—melanoma	2.51e-06	9.25e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—melanoma	2.51e-06	9.24e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—melanoma	2.51e-06	9.22e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—melanoma	2.49e-06	9.17e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—melanoma	2.49e-06	9.17e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK1—melanoma	2.48e-06	9.14e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—melanoma	2.48e-06	9.14e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—melanoma	2.46e-06	9.04e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—melanoma	2.46e-06	9.04e-06	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—melanoma	2.46e-06	9.03e-06	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—melanoma	2.44e-06	8.99e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—melanoma	2.44e-06	8.98e-06	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—melanoma	2.43e-06	8.95e-06	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—melanoma	2.43e-06	8.95e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK1—melanoma	2.4e-06	8.84e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK1—melanoma	2.4e-06	8.84e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—melanoma	2.4e-06	8.84e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—melanoma	2.4e-06	8.84e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—melanoma	2.4e-06	8.84e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—melanoma	2.4e-06	8.82e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	2.36e-06	8.69e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—melanoma	2.35e-06	8.63e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—melanoma	2.34e-06	8.6e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—melanoma	2.31e-06	8.49e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—melanoma	2.3e-06	8.46e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—melanoma	2.29e-06	8.44e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—melanoma	2.29e-06	8.41e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—melanoma	2.27e-06	8.35e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—melanoma	2.27e-06	8.35e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—melanoma	2.21e-06	8.13e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—melanoma	2.19e-06	8.04e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—melanoma	2.16e-06	7.93e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—melanoma	2.16e-06	7.93e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—melanoma	2.12e-06	7.8e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—melanoma	2.12e-06	7.8e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—melanoma	2.12e-06	7.79e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—melanoma	2.11e-06	7.75e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—melanoma	2.09e-06	7.7e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—melanoma	2.09e-06	7.67e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—melanoma	2.09e-06	7.67e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—melanoma	2.09e-06	7.67e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—melanoma	2.04e-06	7.49e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—melanoma	2.04e-06	7.49e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—melanoma	2.02e-06	7.42e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—melanoma	2.02e-06	7.42e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—melanoma	1.99e-06	7.34e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—melanoma	1.95e-06	7.19e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—melanoma	1.93e-06	7.1e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—melanoma	1.93e-06	7.1e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—melanoma	1.93e-06	7.1e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—melanoma	1.91e-06	7.02e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—melanoma	1.85e-06	6.79e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—melanoma	1.85e-06	6.79e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—melanoma	1.84e-06	6.77e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—melanoma	1.76e-06	6.48e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—melanoma	1.7e-06	6.27e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—melanoma	1.7e-06	6.27e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—melanoma	1.6e-06	5.87e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—melanoma	1.56e-06	5.74e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—melanoma	1.5e-06	5.53e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—melanoma	1.27e-06	4.69e-06	CbGpPWpGaD
